Tsumura & Co. (TYO:4540)

Market Cap	279.77B -15.7%
Revenue (ttm)	189.50B +10.3%
Net Income	29.01B +7.0%
EPS	386.55 +8.2%
Shares Out	74.54M
PE Ratio	9.71
Forward PE	10.52
Dividend	152.00 (4.05%)
Ex-Dividend Date	Mar 30, 2026

Volume	175,800
Average Volume	233,325
Open	3,753.00
Previous Close	3,753.00
Day's Range	3,748.00 - 3,780.00
52-Week Range	3,306.00 - 4,450.00
Beta	0.05
RSI	40.04
Earnings Date	May 8, 2026

About Tsumura & Co.

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal and throat inflammation symptoms. It also offers over-the-counter Kampo medicines. The company was founded in 1893 and is headquartered in Tokyo, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 4,272
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4540

Financial Performance

In fiscal year 2025, Tsumura & Co.'s revenue was 181.09 billion, an increase of 20.05% compared to the previous year's 150.85 billion. Earnings were 32.43 billion, an increase of 94.10%.